川控股(01420.HK)附屬與楊自斌訂立投資協議
格隆匯6月3日丨川控股(01420.HK)公吿,於2021年6月3日,公司間接全資附屬公司Chuan Lim(i)與楊自斌訂立投資協議A,據此,Chuan Lim將透過楊投資總額262.5萬新加坡元,重新發展物業A為一棟獨立式洋房,帶有一個地庫、兩層樓及一個閣樓;及(ii)與楊自斌訂立投資協議B,據此,Chuan Lim將透過楊投資總額137.15萬新加坡元,重新發展物業B為一棟獨立式洋房,帶有一個地庫、兩層樓及一個閣樓。
集團將以其內部資源撥付投資協議項下的投資承擔。有關投資將不會以公司附屬公司入賬及其財務業績將不會併入公司賬目。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.